EP3576740
KRABBAMEINSMEÐFERÐ
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.2.2018EP published:
14.6.2023EP application number:
18702299.1
EP translation filed:
14.7.2023Grant published:
15.8.2023EPO information:
European Patent Register
Max expiry date:
1.2.2038Expiry date:
1.2.2027Next due date:
28.2.2027
Title in English:
CANCER TREATMENTLanguage of the patent:
English
Timeline
Today
2.2.2018EP application
14.6.2023EP Publication
14.7.2023Translation submitted
15.8.2023Registration published
1.2.2027Expires
Owner
Name:
Janssen Pharmaceutica NVAddress:
Turnhoutseweg 30, 2340 Beerse, BE
Inventor
Name:
STUYCKENS, KimAddress:
2340 Beerse, BE
Name:
PEREZ RUIXO, Juan, JoseAddress:
28042 Madrid, ES
Name:
DE PORRE, Peter, Marie, Z.Address:
2340 Beerse, BE
Name:
AVADHANI, Anjali, NarayanAddress:
Springhouse Pennsylvania 19477, US
Name:
LORIOT, YohannAddress:
94805 Villejuif Cedex, FR
Name:
SIEFKER-RADTKE, Arlene, O.Address:
2340 Beerse, BE
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201762455211 PDate:
6.2.2017Country:
US
Number:
17209098Date:
20.12.2017Country:
EP
Classification
Categories:
A61K 31/498, G01N 33/574, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 9.1.2024
Expires: 1.2.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 13.1.2025
Expires: 1.2.2026
Payer: Árnason Faktor ehf.
Number: 9
Paid: 4.2.2026
Expires: 1.2.2027
Payer: Árnason Faktor ehf.